VSee Health receives additional Nasdaq delisting notice for equity deficiency; hearing Sept 9

VSEE HEALTH, INC.

Stockholders' equity of -$18,488 as of Dec 31, 2024, below the $2.5M minimum for continued listing.
Company already faces delisting for late filings; hearing before Nasdaq Panel scheduled Sept 9, 2025.
If delisted, expects common stock (VSEE) and warrants (VSEEW) to trade on OTC Markets upon suspension.
No assurance Panel will grant stay, reverse determination, or that company can regain compliance.
Trading has not yet been suspended as of filing date but may be suspended at any time.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.